| Biomarker ID | 1264 |
| PMID | 24358122 |
| Year | 2013 |
| Biomarker | β-catenin |
| Biomarker Basis | Expression Based |
| Biomolecule | mRNA |
| Source | Cell Lines |
| Subjects | Humans |
| Regulation | Upregulated in DU145 and PC-3 |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | DU145, PC-3 Vs CAHPV-10 |
| Type of Biomarker | Prognostic |
| Cohort | Cell lines derived from normal prostate epithelial tissue (PNT2), non-invasive (CAHPV-10) and invasive prostate cancer (LNCaP, DU145, PC-3) were taken for this study |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | DU145 (p=0.006); PC-3 (p=0.001) |
| Method Used | qRT-PCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on human patient cohort |
| Technical Name | NA |